Abacus Global Management, Inc. (ABX)
NYSEFinancialsInsurance - LifeSnapshot 2026-09-04
$9.61-1.44%
Close 2026-09-04 · 1-day change
NYSEFinancialsInsurance - LifeSnapshot 2026-09-04
QuarterlyIQ Insights · ABX
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $9.61 the market pays 2.2× p/b — above the 1.3× p/b peer median but in line with its own 2× history. That premium reflects a durable franchise our peer-anchored $11 fair value understates; treat the 'expensive vs peers' read with medium confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| dcf fcff | 12M | $25.41 | — | — | Analyst | high |
| graham number | 12M | $9.51 | — | — | TTM | high |
| Peer P/B | 12M | $5.92 | 1.3 | 4.41 | TTM | high |
| Peer P/FCF | 12M | $9.97 | 11.1 | 0.90 | TTM | high |
| Peer P/E | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Self-history needs ~20 months of data.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $12.51 |
| 11.2 |
| 1.12 |
| ntm analyst |
| high |
| Peer P/S | 12M | $7.81 | 2.9 | 2.71 | TTM | high |
| PEG | 12M | $25.89 | 28.4 | 0.91 | TTM | high |
| residual income | 12M | $6.06 | — | — | TTM | high |
| triangulated | 12M | $11.77 | 12.4 | 0.95 | Triangulated | high |
| Peer P/B | 3Y | $9.00 | 1.3 | 6.71 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $16.55 | 11.2 | 1.48 | Analyst | medium |
| Peer P/S | 3Y | $12.60 | 2.9 | 4.38 | Analyst | medium |
| PEG | 3Y | $39.37 | 28.4 | 1.38 | Analyst | medium |
| Peer P/B | 5Y | $11.90 | 1.3 | 8.88 | Hist. CAGR(prov.) | medium |
| Peer P/E | 5Y | $21.88 | 11.2 | 1.96 | Analyst | medium |
| Peer P/S | 5Y | $16.67 | 2.9 | 5.79 | Analyst | medium |
| PEG | 5Y | $52.07 | 28.4 | 1.83 | Analyst | medium |